|

Candonilimab Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • West China Hospital1
  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Cancer2
  • Cholangiocarcinoma Non-resectable1
  • Soft Tissue Sarcoma1

Other2 trials

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
Phase 2
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.